Search results for "ZOL"
showing 10 items of 4792 documents
Ferromagnetic coupling through the oxalate bridge in heterobimetallic Cr(III)–M(II) (M = Mn and Co) assemblies
2019
Abstract Two novel compounds, {[Cr(pyim)(ox)2]2Mn}n·2nCH3OH (1) and {[Cr(pyim)(ox)2]2Co(H2O)2}·7.5H2O (2) [pyim = 2-(2′-pyridyl)imidazole and H2ox = oxalic acid], were synthesized by using the mononuclear chromium(III) complex PPh4[Cr(pyim)(ox)2]·H2O (PPh4+ = tetraphenylphosphonium) as metalloligand towards the fully solvated manganese(II) (1) and cobalt(II) (2) ions as perchlorate salts. The structure of 1 consists of neutral double chains, with diamond-shaped units sharing the manganese(II) ions with the two other corners being occupied by the chromium(III) ions. The two metal centres in 1 are connected by bis-bidentate oxalate groups, each [CrIII(pyim)(ox)2]− unit being bound to two mang…
One-dimensional oxalato-bridged heterobimetallic coordination polymers by using [the [Cr(pyim)(C2O4)2]− complex as metalloligand [pyim = 2-(2′-pyridy…
2019
Abstract Four new coordination polymers based on the use of the [Cr(pyim)(C2O4)2]− species as a metalloligand, namely [LiCr(pyim)(C2O4)2(MeOH)]n (1), {[CaCr2(pyim)2(C2O4)4]·2MeOH}n (2), {[SrCr2(pyim)2(C2O4)4(H2O)]·0.45MeOH·4.55H2O}n (3) and {[CdCr2(pyim)2(C2O4)4]·MeOH}n (4) [pyim = 2-(2′-pyridyl)imidazole] have been synthesized and characterized by elemental analyses, IR spectra and X-ray diffraction on single crystals. Complex 1 is a neutral heterobimetallic chain where the tris(chelated) chromium(III) unit acts as a bis-bidentate ligand towards {Li(MeOH)}+ fragments through its two oxalate ligands, each lithium ion being five-coordinate in a intermediate surrounding between square pyramid…
Self-assembly, binding ability and magnetic properties of dicopper(ii) pyrazolenophanes
2016
A novel series of dinuclear copper(II) pyrazolenophanes of the formula [Cu2(μ-4-Mepz)2(μ-ClO4)(ClO4)(bpm)2] (1), [Cu2(μ-pz)2(μ-H2O)(ClO4)(4,7-Me2phen)2]ClO4·H2O·CH3CN (2), [Cu2(μ-pz)2(μ-H2O)(ClO4)3/2(H2O)1/2(phen)2]2[Cu2(μ-pz)2(μ-ClO4)(ClO4)2(phen)2]·8H2O (3), and [Cu2(μ-pz)2(CH3CN)2(3,4,7,8-Me4phen)2](ClO4)2 (4) (Hpz = pyrazole, H-4-Mepz = 4-methylpyrazole, bpm = 2,2'-bipyrimidine, phen = 1,10-phenanthroline, 4,7-Me2phen = 4,7-dimethyl-1,10-phenanthroline, and 3,4,7,8-Me4phen = 3,4,7,8-tetramethyl-1,10-phenanthroline) have been synthesized and magneto-structurally investigated. The crystal structures of 1–4 contain bis(pyrazolate)(perchlorate)- (1 and 3), bis(pyrazolate)(aqua)- (2 and 3), …
Pyrazole and Pyrazolate as Ligands in the Synthesis and Stabilization of New Palladium(II) and (III) Compounds.
2016
The versatility of pyrazole/pyrazolate as ligands has allowed the synthesis and the structural characterization of four different types of new orthometalated palladium compounds, for which DFT calculations have been performed in order to investigate their relative stabilities. [Pd2{μ-(C6H4)PPh2}2{μ-(R,R'2pz)}2] (R = R' = H, 2a; R = Br, R' = H, 2b; R = CH3, R' = H, 2c; R = H, R' = CH3, 2d; R = Br, R' = CH3, 2e) compounds with exo-bidentate pyrazolatos are the first paddlewheel dinuclear palladium(II) compounds with pyrazolato bridging ligands described and characterized in the literature. In the process of the synthesis of 2a, a new tetranuclear intermediate compound, [Pd4{μ-(C6H4)PPh2}4(μ-p…
Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms
2020
In this study cytotoxicity of organotin(IV) compounds with 1,2,4-triazolo[1,5-a]pyrimidines, Me3Sn(5tpO) (1), n-Bu3Sn(5tpO) (2), Me3Sn(mtpO) (3), n-Bu3Sn(mtpO) (4), n-Bu3Sn(HtpO2) (5), Ph3Sn(HtpO2) (6) where 5HtpO = 4,5-dihydro-5-oxo-[1,2,4]triazolo-[1,5-a]pyrimidine, HmtpO = 4,7-dihydro-5-methyl-7-oxo-[1,2,4]triazolo-[1,5-a]pyrimidine, and H2tpO2 = 4,5,6,7-tetrahydro-5,7- dioxo-[1,2,4]triazolo-[1,5-a]-pyrimidine, was assessed on three different human tumor cell lines: HCT-116 (colorectal carcinoma), HepG2 (hepatocarcinoma) and MCF-7 (breast cancer). While 1 and 3 were inactive, compounds 2, 4, 5 and 6 inhibited the growth of the three tumor cell lines with IC50 values in the submicromolar …
Syntheses, crystal structures and magnetic properties of new oxalato-, croconato- and squarato-containing copper(ii) complexesElectronic supplementar…
2003
The preparation and magnetic investigation of five mononuclear copper(II) complexes of formula [Cu(pyim)(C2O4)(H2O)]·2H2O (1), [Cu(pyim)(C4O4)(H2O)2]·2H2O (2), Cu(pyim)(C5O5)·2.5H2O (3), [Cu(H2bim)(C2O4)(H2O)]·H2O (4) and [Cu(bpz)(C5O5)(H2O)] (5) [pyim=2-(2-pyridyl)imidazole, H2bim=2,2′-biimidazole, bpz=2,2′-bipyrazine, C2O42−=dianion of oxalic acid, C4O42−=dianion of squaric acid and C5O52−=dianion of croconic acid] are reported. The crystal structures of 1, 2, 4 and 5 have been determined. The copper atom has a distorted square pyramidal geometry in this family of complexes: two nitrogen atoms from the bidentate nitrogen donor [pyim (1 and 2), H2bim (4) and bpz (5)] and two oxygen atoms e…
Novel Cu(II)-Based Frameworks Built from BIMAM and Oxalate: Syntheses, Structures, and Magnetic Characterizations (BIMAM = Bis(imidazol-yl) methylami…
2008
Complexes with the formula [Cu(HBIMAM)(C2O4)]2[Cu(C2O4)2(OH2)2] (1) and [{Cu(HBIMAM)(OH2)(OClO3)}2(μ-C2O4)] (ClO4)2 (2) have been synthesized from copper(II) perchlorate, bis(imidazol-yl) methylami...
Preparation, crystal structures and magnetic properties of three thiocyanato-bridged copper(II) complexes with 2,2′-biimidazole or 2-(2′-pyridyl)imid…
2009
The synthesis, crystal structures and variable temperature magnetic investigation of three new thiocyanato-bridged copper(II) complexes with 2,2′-biimidazole (H2bim) or 2-(2′-pyridyl)imidazole) (pyim) as coligands, {[Cu(H2bim)2][Cu(H2bim)(NCS)2(SCN)0.6667(NO3)0.3333]2} · 2H2O (1), [Cu(H2bim)(NCS)2]n (2) and [Cu(pyim)(NCS)2]n (3) are reported. Complex 1 contains centrosymmetric trinuclear species where central [Cu(2)(H2biim)2]2+ cations and peripheral [Cu(1)(H2biim)(NCS)2(SCN)]− anions are linked through single end-to-end thiocyanato bridges. Complexes 2 and 3 are made up of neutral zigzag chains of copper(II) ions linked by single (2) and double (3) end-to-end thiocyanato bridges. A bidenta…
Coordination behaviour of sulfanilamide derivatives.
2000
Abstract Hg(II), Cd(II) and Zn(II) complexes with the ligands sulfadimethoxine, sulfamethoxypyridazine, sulfadiazine, sulfamerazine, sulfadimidine and sulfamethoxazole have been prepared and characterised by spectral data. 1H and 13C NMR have been used to interpret the structural characteristics of the complexes in solution. The X-ray crystal structures of [Hg(sulfamethoxypyridazinato)2] (2a), [Cd(sulfadimidinato)2(H2O)]·2H2O (4b) and [Zn(sulfamethoxazolato)2(py)2(H2O)2] (6d) have been determined. In complex 2a the Hg(II) ion lies on an inversion centre and exhibits linear coordination by two sulfonamidic nitrogen atoms [Hg–N(1)=2.071(4) A] of the two deprotonated sulfamethoxypyridazinato l…
Tin(IV) and organotin(IV) complexes containing mono or bidentate N-donor ligands
1998
Abstract A series of adducts of the type [(L # ) y R n SnX 4− n ]· z H 2 O (L # =1-methylimidazole, y =1 or 2, R=Me, Et, Bu n or Ph, n =1, 2 or 3, X=Cl, Br or I, z =0, 1/2 or 1) has been characterized in the solid state and in solution by analyses, spectral (IR, 119 Sn Mossbauer, and 1 H, 13 C and 119 Sn NMR) data and conductivity measurements. The molecular weight determinations and the NMR data indicate that these organotin(IV) complexes partly dissociate in chloroform and acetone solution. The donor L # interacts with [(CH 3 ) 3 SnNO 3 ], yielding the 2:1 ionic complex [(L # ) 2 (CH 3 ) 3 Sn]NO 3 . The derivative [(L # ) 2 (CH 3 ) 2 SnCl 2 ] reacts with NaClO 4 , AgNO 3 , NaBPh 4 and KSC…